Development of New Drugs that Act Through Membrane Receptors and Involve an Action of Inverse Agonism
Recent Patents on CNS Drug Discovery · 2006
DOI: 10.2174/157488906777452730 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Recent Patents on CNS Drug Discovery, 2006. Verfasst von Rafael Rodríguez-Puertas und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Faculty of Medicine, University of the Basque Country, 48940- Leioa, Vizcaya, Spain. rafael.rodriguez@ehu.es. Hauptthemen laut MEDLINE: Drug Design, Drug Inverse Agonism. Die Arbeit wurde bisher 9-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, Faculty of Medicine, University of the Basque Country, 48940- Leioa, Vizcaya, Spain. rafael.rodriguez@ehu.es
Zitieren
APA
Rodríguez-Puertas, R., & Barreda-Gómez, G. (2006). Development of New Drugs that Act Through Membrane Receptors and Involve an Action of Inverse Agonism. Recent Patents on CNS Drug Discovery. https://doi.org/10.2174/157488906777452730
Vancouver
Rodríguez-Puertas R, Barreda-Gómez G. Development of New Drugs that Act Through Membrane Receptors and Involve an Action of Inverse Agonism. Recent Patents on CNS Drug Discovery. 2006. doi:10.2174/157488906777452730
BibTeX
@article{RodrguezPuertas2006,
author = {Rodríguez-Puertas, Rafael and Barreda-Gómez, Gabriel},
title = {Development of New Drugs that Act Through Membrane Receptors and Involve an Action of Inverse Agonism},
journal = {Recent Patents on CNS Drug Discovery},
year = {2006},
doi = {10.2174/157488906777452730}
}
EUVIMED